Toxic shock syndrome history and symptoms: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 32: Line 32:
**[[dizziness]] or [[syncope]]
**[[dizziness]] or [[syncope]]
*Diffuse [[erythroderma]]
*Diffuse [[erythroderma]]
*[[edema]] of the extremities
*[[Edema]] of the extremities
*[[Shortness of breath]] and [[orthopnea]] (as a result of pulmonary edema and pleural effusion secondary to the sock complication)
*[[Headaches]]


=== Less common symptoms ===
=== Less common symptoms ===
*[[desquamation]] of [[Palms of the hands|palms]] and [[Sole (foot)|soles]] which particularly begins 1-3 weeks after disease beginning<ref name="urlTintinallis Emergency Medicine: A Comprehensive Study Guide, 8th edition - Judith Tintinalli, J. Stapczynski, O. John Ma, David M. Cline, Garth Meckler - Google Books">{{cite web |url=https://books.google.com/books?id=FNKLCgAAQBAJ&q=It%27s+main+characteristics+involve+diffuse,+red,+macular+rash+resembling+sunburn+that+can+also+involve+the+palms+and+soles.&dq=It%27s+main+characteristics+involve+diffuse,+red,+macular+rash+resembling+sunburn+that+can+also+involve+the+palms+and+soles.&hl=en&sa=X&ved=0ahUKEwjlq-LXoODTAhVF7CYKHQ3aDkoQ6AEIJzAA |title=Tintinalli's Emergency Medicine: A Comprehensive Study Guide, 8th edition - Judith Tintinalli, J. Stapczynski, O. John Ma, David M. Cline, Garth Meckler - Google Books |format= |work= |accessdate=}}</ref>  
*[[desquamation]] of [[Palms of the hands|palms]] and [[Sole (foot)|soles]] which particularly begins 1-3 weeks after disease beginning<ref name="urlTintinallis Emergency Medicine: A Comprehensive Study Guide, 8th edition - Judith Tintinalli, J. Stapczynski, O. John Ma, David M. Cline, Garth Meckler - Google Books">{{cite web |url=https://books.google.com/books?id=FNKLCgAAQBAJ&q=It%27s+main+characteristics+involve+diffuse,+red,+macular+rash+resembling+sunburn+that+can+also+involve+the+palms+and+soles.&dq=It%27s+main+characteristics+involve+diffuse,+red,+macular+rash+resembling+sunburn+that+can+also+involve+the+palms+and+soles.&hl=en&sa=X&ved=0ahUKEwjlq-LXoODTAhVF7CYKHQ3aDkoQ6AEIJzAA |title=Tintinalli's Emergency Medicine: A Comprehensive Study Guide, 8th edition - Judith Tintinalli, J. Stapczynski, O. John Ma, David M. Cline, Garth Meckler - Google Books |format= |work= |accessdate=}}</ref>  
*[[Confusion]] or [[agitation]] (as a result of [[Toxic shock syndrome|TSS]] complications e.g. [[encephalopathy]])<ref name="pmid2928649">{{cite journal |vauthors=Olson RD, Stevens DL, Melish ME |title=Direct effects of purified staphylococcal toxic shock syndrome toxin 1 on myocardial function of isolated rabbit atria |journal=Rev. Infect. Dis. |volume=11 Suppl 1 |issue= |pages=S313–5 |year=1989 |pmid=2928649 |doi= |url=}}</ref>
*[[Confusion]] or [[agitation]], [[memory loss]], [[disorientation]] and poor [[concentration]] (as a result of [[Toxic shock syndrome|TSS]] complications e.g. [[encephalopathy]])<ref name="pmid2928649">{{cite journal |vauthors=Olson RD, Stevens DL, Melish ME |title=Direct effects of purified staphylococcal toxic shock syndrome toxin 1 on myocardial function of isolated rabbit atria |journal=Rev. Infect. Dis. |volume=11 Suppl 1 |issue= |pages=S313–5 |year=1989 |pmid=2928649 |doi= |url=}}</ref>
*[[Somnolence]], [[irritability]], [[agitation]], and [[Hallucination|hallucinations]]
*[[Stupor]] or [[coma]] <ref name="pmid7091958">{{cite journal |vauthors=Rosene KA, Copass MK, Kastner LS, Nolan CM, Eschenbach DA |title=Persistent neuropsychological sequelae of toxic shock syndrome |journal=Ann. Intern. Med. |volume=96 |issue=6 Pt 2 |pages=865–70 |year=1982 |pmid=7091958 |doi= |url=}}</ref>
*[[Stupor]] or [[coma]] <ref name="pmid7091958">{{cite journal |vauthors=Rosene KA, Copass MK, Kastner LS, Nolan CM, Eschenbach DA |title=Persistent neuropsychological sequelae of toxic shock syndrome |journal=Ann. Intern. Med. |volume=96 |issue=6 Pt 2 |pages=865–70 |year=1982 |pmid=7091958 |doi= |url=}}</ref>
*[[Dyspnea]] (as a result of [[pulmonary edema]] and [[pleural effusion]])
*[[Dyspnea]] (as a result of [[pulmonary edema]] and [[pleural effusion]])

Revision as of 23:39, 13 May 2017

Toxic shock syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxic Shock Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxic shock syndrome history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxic shock syndrome history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxic shock syndrome history and symptoms

CDC on Toxic shock syndrome history and symptoms

Toxic shock syndrome history and symptoms in the news

Blogs on Toxic shock syndrome history and symptoms

Directions to Hospitals Treating Toxic shock syndrome

Risk calculators and risk factors for Toxic shock syndrome history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]

Overview

A positive history of tampon usage is suggestive of staphylococcal toxic shock syndrome(TSS) and a positive history of recent extremity trauma is suggestive of Streptococcal TSS (the most common causes of disease). The most common symptoms of TSS include fever, erythroderma, and general viral infection symptoms like myalgia.

Less common symptom of TSS include desquamation (which occur after 1-3 weeks of disease onset).

History

It is necessary to obtain a detailed and thorough history from the patient to diagnose the type of TSS and determine its severeness. It provides insight into cause, precipitating factors and associated comorbid conditions. Complete history will help determine the correct therapy and helps in determining the prognosis. TSS patients may be disoriented due to encephalopathy complication therefore the patient interview may be difficult. In such cases history from the care givers or the family members may need to be obtained. Specific histories about the symptoms (duration, onset, progression), associated symptoms, and past medical history have to be obtained.

Specific areas of focus when obtaining a history from the patient include:

General symptoms

These symptoms are common and can be found in all different causes of TSS. These are usually related to the shock itself and the hypersensitivity reaction which is related to bacterial antigen:

Common Symptoms

Less common symptoms

Specific associated History and symptoms

Staphylococcal TSS

  • Tampon usage

Streptococcal TSS

Clostridium sordellii TSS


TSS different causes and their symptoms

type symptoms
Staphylococcal TSS menstural Skin manifestations: erythroderma

Conjunctival-scleral hemorrhage and hyperemia of the vaginal and oropharyngeal mucosa

non-menstural
Streptococcal TSS GAS-related NF skin and cutaneous lesions:

General Shock Signs: fever, hypotension, chills, malaise, sore throat, fatigue, myalgias, headache, abdominal pain, diarrhea, vomiting and orthostatic hypotension with dizziness or syncope

Clostridium sordellii TSS - nonspecific primary symptoms that may be misdiagnosed with viral infections like flu (nausea, vomiting, lethargy, influenza-like symptoms, and abdominal tenderness)

skin infection, bacteremia, and organ specific infections such as pneumonia, empyema, endocarditis, septic arthritis, and surgical site infection

References

  1. Wharton M, Chorba TL, Vogt RL, Morse DL, Buehler JW (1990). "Case definitions for public health surveillance". MMWR Recomm Rep. 39 (RR-13): 1–43. PMID 2122225.
  2. "Tintinalli's Emergency Medicine: A Comprehensive Study Guide, 8th edition - Judith Tintinalli, J. Stapczynski, O. John Ma, David M. Cline, Garth Meckler - Google Books".
  3. Olson RD, Stevens DL, Melish ME (1989). "Direct effects of purified staphylococcal toxic shock syndrome toxin 1 on myocardial function of isolated rabbit atria". Rev. Infect. Dis. 11 Suppl 1: S313–5. PMID 2928649.
  4. Rosene KA, Copass MK, Kastner LS, Nolan CM, Eschenbach DA (1982). "Persistent neuropsychological sequelae of toxic shock syndrome". Ann. Intern. Med. 96 (6 Pt 2): 865–70. PMID 7091958.
  5. Chesney RW, Chesney PJ, Davis JP, Segar WE (1981). "Renal manifestations of the staphylococcal toxic-shock syndrome". Am. J. Med. 71 (4): 583–8. PMID 7282746.
  6. Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, Kaplan E (1989). "Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A". N. Engl. J. Med. 321 (1): 1–7. doi:10.1056/NEJM198907063210101. PMID 2659990.
  7. Adams EM, Gudmundsson S, Yocum DE, Haselby RC, Craig WA, Sundstrom WR (1985). "Streptococcal myositis". Arch. Intern. Med. 145 (6): 1020–3. PMID 3890787.
  8. Nuwayhid ZB, Aronoff DM, Mulla ZD (2007). "Blunt trauma as a risk factor for group A streptococcal necrotizing fasciitis". Ann Epidemiol. 17 (11): 878–81. doi:10.1016/j.annepidem.2007.05.011. PMC 4029051. PMID 17697787.
  9. Aldape MJ, Bryant AE, Stevens DL (2006). "Clostridium sordellii infection: epidemiology, clinical findings, and current perspectives on diagnosis and treatment". Clin. Infect. Dis. 43 (11): 1436–46. doi:10.1086/508866. PMID 17083018.
  10. Foroulis CN, Gerogianni I, Kouritas VK, Karestsi E, Klapsa D, Gourgoulianis K, Petinaki E (2007). "Direct detection of Clostridium sordellii in pleural fluid of a patient with pneumonic empyema by a broad-range 16S rRNA PCR". Scand. J. Infect. Dis. 39 (6–7): 617–9. doi:10.1080/00365540601105798. PMID 17577829.
  11. Spera RV, Kaplan MH, Allen SL (1992). "Clostridium sordellii bacteremia: case report and review". Clin. Infect. Dis. 15 (6): 950–4. PMID 1457666.


Template:WikiDoc Sources